https://www.selleckchem.com/products/itf3756.html
Bacterial gastroenteritis forms a burden on a global scale, both socially and economically. The Gram-positive bacterium Clostridium difficile is an inducer of gastrointestinal bacterial infections, often triggered following disruption of the microbiota by broad-spectrum antibiotics to treat other conditions. The clinical manifestatiaons, e.g., diarrhea, are driven by its toxins secretion, toxin A (TcdA) and toxin B (Tcd. Current therapies are focused on discontinuing patient medication, including antibiotics. However, relapse rates up
Gefällt mir
Kommentar
Teilen
